D6567

DRF 2519

≥98% (HPLC), solid

• Synonym(e): 5-[[4-[2-(4-Oxo-2H-1,3-benzoxazin3(4H)-yl)ethoxy]phenyl]methyl2,4-thiazolidinedione
• Empirische Formel (Hill-System): C₂₀H₁₈N₂O₅S
• Molekulargewicht: 398.43
• MDL-Nummer: MFCD06798336
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 24894036

Eigenschaften

• Assay: ≥98% (HPLC)
• Form: solid
• Lagerbedingungen: under inert gas
• Farbe: white
• Löslichkeit: DMSO: ≥10 mg/mL
• Lagertemp.: 2-8°C
• SMILES String: O=C1NC(=O)C(Cc2ccc(OCCN3COc4ccccc4C3=O)cc2)S1

Beschreibung

Biochem./physiol. Wirkung

DRF-2519 is a dual PPARα/γ activator. DRF-2519 has better reduction of plasma insulin, triglyceride, and free fatty acid levels than those treated with rosiglitazone.

Sicherheitshinweise

• Lagerklassenschlüssel: 13 - Non Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable
• Persönliche Schutzausrüstung: Eyeshields, Gloves, type N95 (US)